Clinical Oncology Letters
https://clinicaloncologyletters.com/article/doi/10.4322/col.2019.006
Clinical Oncology Letters
Relato de Caso

Manejo e Tratamento da Radiodermite em Pacientes Oncológicos: Série de Casos

Management and Treatment of Radiodermatitis in Cancer Patients: Case Series

Karine Corcione Turke, Jean Henri Maselli Schoueri, Amanda Voltareli C. Oliveira, Vinicius Lippi, Fernanda Laraia da Rocha Lobo, Julian Gonzalez Fraga, Camila Campos, Vanessa Salzano, Carlos D’Apparecida Machado, Auro del Giglio, Dolores Gonzalez Fabra

Downloads: 12
Views: 1480

Resumo

No presente artigo, apresentamos uma série de três casos de pacientes em acompanhamento oncológico que desenvolveram lesões cutâneas por radioterapia – Radiodermite -, acompanhado de uma revisão integrativa da literatura médica. Apesar de frequente na prática clínica e de apresentar repercussões em ambos, tratamento e qualidade de vida do indivíduo, há poucos casos na literatura sobre o manejo dermatológico de pacientes oncológicos.

Palavras-chave

Radiodermite; Tratamento; Relato de caso

Abstract

In the present article, we present a series of three cases of patients undergoing cancer treatment who developed skin lesions by radiotherapy - Radiodermatitis -, alongside with an integrative review of the medical literature. Despite being frequent in clinical practice and having repercussions on both treatment and quality of life of the individual, there are few cases in the literature on the dermatological management of cancer patients.

Keywords

Radiodermatitis; Treatment; Case Report

Referências

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7-30. http://dx.doi.org/10.3322/caac.21332. PMid:26742998.

2. Sudhakar A. History of cancer, ancient and modern treatment methods. J Cancer Sci Ther. 2009;1(2):1-4. http://dx.doi.org/10.4172/1948-5956.100000e2. PMid:20740081.

3. Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012;9(3):193-9. http://dx.doi.org/10.7150/ijms.3635. PMid:22408567.

4. Singh M, Alavi A, Wong R, Akita S. Radiodermatitis: a review of our current understanding. Am J Clin Dermatol. 2016;17(3):277-92. http://dx.doi.org/10.1007/s40257-016-0186-4. PMid:27021652.

5. National Center for Biotechnology Information. Mesh definition [Internet]. Bethesda: NCBI; 2017 [cited 2017 Aug 24]. Available from: https://www.ncbi.nlm.nih.gov/mesh/68011855

6. Hu SC, Hou MF, Luo KH, et al. Changes in biophysical properties of the skin following radiotherapy for breast cancer. J Dermatol. 2014;41(12):1087-94. http://dx.doi.org/10.1111/1346-8138.12669. PMid:25354814.

7. De Langhe S, Mulliez T, Veldeman L, et al. Factors modifying the risk for developing acute skin toxicity after wholebreast intensity modulated radiotherapy. BMC Cancer. 2014;14(1):711. http://dx.doi.org/10.1186/1471-2407-14-711.

8. Fabra DG, Salzano V, Guglielnino F, Kayo AP. Impacto do ambulatório de reabilitação dermatocosmiátrica na qualidade de vida dos pacientes oncológicos da Faculdade de Medicina do ABC. Arq Bras Ciên Saúde, Santo André. 2010;35(2):89-94. http://dx.doi.org/10.7322/abcs.v35i2.92.

9. Kraus-Tiefenbacher U, Sfintizky A, Welzel G, et al. Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS). Radiat Oncol. 2012;7(1):217. http://dx.doi.org/10.1186/1748-717X-7-217. PMid:23249653.

10. Bazire L, Fromantin I, Diallo A, et al. Hydrosorb® versus control (water based spray) in the management of radioinduced skin toxicity: Results of multicentre controlled randomized trial. Radiother Oncol. 2015;117(2):229-33. http://dx.doi.org/10.1016/j.radonc.2015.08.028. PMid:26328937.

11. Heyer E, Smyth W, Laffin N, Gardner A. Protocol paper: a randomized trial of 2 creams in the skin care of patients receiving radiation therapy for breast cancer in the tropics. Cancer Nurs. 2015;38(4):E35-41. http://dx.doi.org/10.1097/NCC.0000000000000175. PMid:25075645.

12. Devlin JW, Skrobik Y, Gélinas C, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46(9):e825- 73. http://dx.doi.org/10.1097/CCM.0000000000003299. PMid:30113379.

13. Franco P, Potenza I, Moretto F, et al. Hypericum perforatum and neem oil for the management of acute skin toxicity in head and neck cancer patients undergoing radiation or chemo-radiation: a single-arm prospective observational study. Radiat Oncol. 2014;9(1):297. http://dx.doi.org/10.1186/s13014-014-0297-0. PMid:25544371.

14. Wong RKS, Bensadoun RJ, Boers-Doets CB, et al. Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group. Support Care Cancer. 2013;21(10):2933-48. PMid:23942595.

15. Sampaio SAP, Castro RM, Rivitti EA. Dermatologia básica. 3. ed. São Paulo: Artes Médicas; 1983.

16. Pires AMT, Araujo SR, Segreto HRC. Avaliação das reações agudas da pele e seus fatores de risco em pacientes com câncer de mama submetidas à radioterapia. Rev Lat Am Enfermagem. 2008;16(5):844-9. http://dx.doi.org/10.1590/S0104-11692008000500008.

17. Gieringer M, Gosepath J, Naim R. Radiotherapy and wound healing: principles, management and prospects. Oncol Rep. 2011;26(2):299-307. http://dx.doi.org/10.3892/or.2011.1319. PMid:21617873.

18. Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol. 2008;26(13):2085-92. http://dx.doi.org/10.1200/JCO.2007.15.2488. PMid:18285602.

19. Freedman GM, Li T, Nicolaou N, Chen Y, Ma CC-M, Anderson PR. Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation. Int J Radiat Oncol Biol Phys. 2009;74(3):689-94. http://dx.doi.org/10.1016/j.ijrobp.2008.08.071. PMid:19362779.

20. Kouloulias V, Thalassinou S, Platoni K, et al. The treatment outcome and radiation-induced toxicity for patients with head and neck carcinoma in the IMRT era: a systematic review with dosimetric and clinical parameters. BioMed Res Int. 2013;2013:401261. http://dx.doi.org/10.1155/2013/401261. PMid:24228247.

21. Clavel S, Nguyen DH, Fortin B, et al. Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2012;82(2):582-9. http://dx.doi.org/10.1016/j.ijrobp.2010.10.061. PMid:21277695.

22. Nutting CM, Morden JP, Harrington KJ, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011;12(2):127-36. http://dx.doi.org/10.1016/S1470-2045(10)70290-4. PMid:21236730.

23. Chao KSC, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys. 2001;49(4):907-16. http://dx.doi.org/10.1016/S0360-3016(00)01441-3. PMid:11240231.

24. Lee NY, Arruda FF, Puri DR, et al. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2006;66(4):966-74. http://dx.doi.org/10.1016/j.ijrobp.2006.06.040. PMid:17145527.

25. Lambrecht M, Nevens D, Nuyts S. Intensity-modulated radiotherapy versus parotid-sparing 3D conformal radiotherapy: effect on outcome and toxicity in locally advanced head and neck cancer. Strahlenther Onkol. 2013;189(3):223-9. http://dx.doi.org/10.1007/s00066-012-0289-7. PMid:23319256.

26. Vissink A, Burlage FR, Spijkervet FKL, Jansma J, Coppes RP. Prevention and treatment of the consequences of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14(3):213-25. http://dx.doi.org/10.1177/154411130301400306. PMid:12799324.

27. Maes A, Weltens C, Flamen P, et al. Preservation of parotid function with uncomplicated conformal radiotherapy. Radiother Oncol. 2002;63(2):203-11. http://dx.doi.org/10.1016/S0167-8140(02)00013-0. PMid:12063010.

28. Rocha DM, Pedrosa AO, Oliveira AC, Bezerra SMG, Benício CDAV, Nogueira LT. Evidências científicas sobre os fatores associados à qualidade de vida de pacientes com radiodermatite. Rev Gaúcha Enferm. 2018;39:e2017-0224. http://dx.doi.org/10.1590/1983-1447.2018.2017-0224.

29. Oliveira HF, Trevisan FA, Bighetti VM, et . Radioterapia de intensidade modulada (IMRT) para pacientes do SUS: análise de 508 tratamentos em dois anos de instalação da técnica. Radiol Bras. 2014;47(6):355-60. http://dx.doi.org/10.1590/0100-3984.2013.1905. PMid:25741118.

5f1095e70e8825ca215a5968 col Articles
Links & Downloads

Clin Onc Let

Share this page
Page Sections